申请人:Abbott Laboratories
公开号:US08278311B2
公开(公告)日:2012-10-02
The present application describes substituted pyrimidine compounds of formula (I)
wherein X, A1, R1, R2, R3, R4, R5, R6, R7, R8, R9, p, q, r, v, and w are defined in the specification, compositions comprising such compounds, methods for making the compounds, and methods of treating and preventing the progression of diseases, conditions and disorders using such compounds and compositions.
本申请描述了公式(I)的取代嘧啶化合物,其中X,A1,R1,R2,R3,R4,R5,R6,R7,R8,R9,p,q,r,v和w在说明书中有定义,包括这种化合物的组成物,制备这种化合物的方法,以及使用这种化合物和组成物治疗和预防疾病,病状和疾病的进展的方法。